Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound?

Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Jun 4, 2026

Alger SICAV - Alger Small Cap Focus Fund Q1 2026 Portfolio Update

During the first quarter of 2026, the largest portfolio sector weightings were Health Care and Industrials. RBC Bearings Incorporated, Cognex Corporation and Nebius Group were among the top contributors to performance. Repligen Corporation, Agilysys, Inc., and GeneDx Holdings Corp. were among the top detractors from performance.

Seeking Alpha • Jun 4, 2026

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Repligen Corporation (RGEN) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Seeking Alpha • Jun 3, 2026

Repligen Has A Cleaner Recovery Angle, But With High Valuation

Repligen is recovering after a difficult 2024, with Q1 2026 revenue up 15% and 11% organic. Polymem, China, PAT, and the Transformation Office make the story cleaner, but execution still matters.

Seeking Alpha • May 31, 2026

Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Conference in Chicago, IL. Olivier Loeillot, President and Chief Executive Officer, will present a company overview on June 3rd at 10:40 a.m. CT.

GlobeNewsWire • May 22, 2026

Repligen Announces Publication of the Company's 2025 Corporate Sustainability Report

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of its 2025 Corporate Sustainability Report and related reporting framework disclosures. Themed “Driving Sustainable Growth Together”, this report communicates the company's progress in advancing our sustainability strategy across six key impact areas: Products & Packaging, Operations, Talent, Supply Chain, Communities, and Pathways to Success. Also included in the 2025 Sustainability Report are detailed disclosures aligned with the United Nations Sustainable Development Goals (UN SDGs) and three key reporting frameworks: the Global Reporting Initiative (GRI) Standards, Sustainability Accounting Standards Board (SASB) Standards and the Task Force on Climate-related Financial Disclosures (TCFD), now part of the IFRS Sustainability Alliance.

GlobeNewsWire • May 20, 2026

Alger Mid Cap 40 ETF Q1 2026 Portfolio Movers

Comfort Systems USA, Inc. shares contributed positively after the company delivered better-than-expected fiscal fourth-quarter results. FTAI Aviation Ltd. launched FTAI Power to convert retired engines into gas turbines for AI-driven data centers, capturing significant investor enthusiasm and opening an entirely new addressable market. Vertiv Holdings Co. delivered strong fiscal fourth-quarter results and issued full-year revenue guidance well ahead of consensus expectations.

Seeking Alpha • May 14, 2026

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • May 12, 2026

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Bank of America Securities 2026 Global Healthcare Conference, being held May 12-14 in Las Vegas, Nevada.

GlobeNewsWire • May 7, 2026

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

RGEN tops Q1 earnings and revenue estimates, sending shares higher as strong chromatography and analytics business aid growth. The company raises its 2026 EPS view.

Zacks Investment Research • May 6, 2026